|
You Me At Six meet cancer patients before gig
Nottingham Post The band met patients, played pool, posed for photos and signed autographs. David Ajala, 23, of Mansfield, who is undergoing check-ups after a stem cell transplant said: “Meeting the band really made my day and lifted my spirits. It was great to chat … |
|
Pat’s Place: When The End Isn’t The End
The Myeloma Beacon My friend’s doctors had prescribed the standard of care: Revlimid-Velcade-dexamethasone induction, a stem cell transplant, and Revlimid maintenance. And after he relapsed? Kyprolis and Pomalyst. All of these drugs are FDA-approved for the treatment of … |
IFB employees sign-up as eye donorsWinston-Salem Chronicle… second largest eye bank in the United States. Its mission is to recover, process and distribute ocular tissue for the restoration of sight through corneal transplantation and related medical…
|
FDA Accepts Omeros IND App for TMA Treatment
Drug Discovery & Development … Phase 2 clinical trial, planned to begin later this quarter, will evaluate the effects of the drug on patients with TMAs, including atypical hemolytic uremic syndrome (aHUS), thrombotic thrombocytopenic purpura (TTP), and stem cell transplant … |
Rock the Puzzle, Musical Fashionation, Women in Sports and Events luncheon …The Plain Dealer$100 minimum donation. Certified divers form a team or be paired with other divers to assemble a giant 220-piece puzzle underwater. Includes commemorative t-s…
|
Actinium CEO Interviewed for “Small Stocks: Big Money” Airing on Fox Business …
Wall Street Journal The Company’s lead radiopharmaceutical Iomab(TM)-B will be used in preparing patients for hematopoietic stem cell transplant, commonly referred to as bone marrow transplant. The Company is preparing a single, pivotal, multicenter Phase 3 clinical study … |
Ride to Conquer Cancer gives goal to multiple myeloma patientOceanside StarHe underwent a stem cell transplant later that year and has been getting regular chemotherapy treatments since November. The chemotherapy treatment consists of taking Revlimid p…
Investigational New Drug Application Cleared by FDA for OMS721 in Thrombotic …MarketWatch… OMS721 Phase 2 clinical trial, planned to begin later this quarter, will evaluate the effects of the drug on patients with TMAs, including atypical hemolytic…
|
Kamada Announces US Proof-of-Concept Study with Glassia® for Graft-Versus …
Business Wire (press release) The POC study is a Phase 1/2 study of 24 patients with steroid-resistant GVHD following allogeneic bone-marrow stem cell transplant who will receive six to ten doses of intravenously delivered Glassia to determine safety, optimal dose and clinical … |
Could transplant drugs replace antiretrovirals in HIV treatment?Medical News Today… study – by researchers at the University of California, San Francisco and published in the American Journal of Transplantation – also refers to research from 2009 tha…